-
Ricola enters immunity category
PARSIPPANY, N.J. - Ricola on Thursday announced the release of Ricola Herbal Immunity Lozenges, formulated with ginseng, vitamins C, B6 and B12, to help support the immune system and fight fatigue.
"The immunity category has exploded in recent years," stated William Higgins, regional president, North America at Ricola. "We are excited to expand our product portfolio into the category and bring consumers a proactive approach to wellness."
-
Seqirus' Afluria Quadrivalent influenza vaccine approved by FDA
CAMBRIDGE, Mass. - Seqirus announced today that the U.S. Food and Drug Administration has approved Afluria Quadrivalent (Influenza Vaccine) for use in persons 18 years of age and older. Afluria Quadrivalent is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.